Increasing investments in research activities, government funding, technical developments in HTS and venture capital funding is primarily driving the HTS market size across the globe. Multiple initiatives taken by the biotechnology and pharmaceutical companies is further advancing the HTS industry growth. For instance, in April 2018, Corning Incorporated announced to highlight latest solutions for cancer research, drug discovery, 3D cell culture, at the 2018 American Association for Cancer Research held in Chicago.
The High Throughput Screening Market is expected to around US$ 28.50 Billion in 2028, at a CAGR of 7.5% during the forecast period.
Tightening government rules and regulations to improve the quality control standards to attain accuracy and integrity on the data and information gained and stored. However, inefficient software that are unable to manage liquid handing systems and automated robotic arms is expected to downturn the market growth over the foreseeable time line.
Global high throughput screening market is segmented based on the technology as Cell-Based Assays, Lab on a Chip, and Bioinformatics. Based on products, the HTS industry can be segmented into Reagent, Instruments, Software, and Service. On the basis of application, the global high throughput screening market is segregated as Target Identification, Primary Screening, and Toxicology. The report segments global high throughput screening market based on end-use as Pharmaceutical & Biotechnology Companies, Academic & Government Institutes, and Contract Research Organizations.
Global high throughput screening market report covers various regions including North America, Europe, Asia Pacific, and Rest of World. The regional high throughput screening market is further bifurcated for major countries including U.S., Canada, Germany, UK, France, Italy, China, India, Japan, Brazil, South Africa and others.
Competitive Rivalry
Global high throughput screening market share consists of several players including Thermo Fisher Scientific, Agilent Technologies, Danaher Corporation, Perkinelmer, Tecan Group, Axxam, Bio-Rad Laboratories, Merck Group, Hamilton Company, Corning Incorporated, Biotek Instruments, and Aurora Biomed. Rising competition among the industry players to commercialize novel molecules is encouraging them to adopt innovative technologies which will aid in minimizing drug development time.
The High Throughput Screening Market has been segmented as below:
High Throughput Screening Market, By Technology
High Throughput Screening Market, By Product
High Throughput Screening Market, By Application
High Throughput Screening Market, By End-User
High Throughput Screening Market, By Region
The report covers:
Report scope:
The global high throughput screening market report covers detailed study with the underlying influencing factors for the variations in the industry growth trends.
The report scope includes market analysis on regional as well as country level. The report also provides competitive landscape covering company market shares with detailed profiling for major revenue contributing companies.
The report covers a detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Merck Group, Hamilton Company, Corning Incorporated, Biotek Instruments, Thermo Fisher Scientific and Agilent Technologies.
Reasons to Buy this Report:
Customization:
Customized report as per the requirement can be offered with appropriate recommendations
Below are our new reports:
1. Introduction
1.1. Key Points
1.2. Report Description
1.3. Markets Covered
1.4. Stakeholders
2. Research Methodology
2.1. Research Scope
2.2. Research Methodology
2.2.1. Market Research Process
2.2.2. Research Methodology
2.2.2.1. Secondary Research
2.2.2.2. Primary Research
2.2.2.3. Models for Estimation
2.3. Market Size Estimation
2.3.1. Bottom-Up Approach
2.3.2. Top-Down Approach
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Drivers
4.2.1. Technological Advancements
4.2.2. Government Funding and Venture Capital Investments
4.2.3. Increasing adoption of Open Innovation Models in Pharmaceutical and Biotechnology Companies
4.3. Restraints
4.3.1. Capital-Intensive
4.3.2. Technical complexity
4.4. Opportunities
4.4.1. Emerging Markets
4.4.2. Rising R&D investment in Toxicology and Stem Cells
4.5. Challenges
4.5.1. Dearth of Skilled Operators
5. High Throughput Screening Market, By Technology
5.1. Key Points
5.2. Cell-Based Assays
5.3. Lab on a Chip
5.4. Bioinformatics
6. High Throughput Screening Market, By Product
6.1. Key Points
6.2. Reagent
6.3. Instruments
6.4. Software
6.5. Service
7. High Throughput Screening Market, By Application
7.1. Key Points
7.2. Target Identification
7.3. Primary Screening
7.4. Toxicology
8. High Throughput Screening Market, By End-Use
8.1. Key Points
8.2. Pharmaceutical & Biotechnology Companies
8.3. Academic and Government Institutes
8.4. CRO
9. Competitive Landscape
9.1. Introduction
9.2. Recent Developments
9.2.1. Mergers & Acquisitions
9.2.2. New Product Developments
9.2.3. Portfolio/Production Capacity Expansions
9.2.4. Joint Ventures, Collaborations, Partnerships & Agreements
9.2.5. Others
10. Company Profile
10.1. Thermo Fisher Scientific Inc.
10.1.1. Company Overview
10.1.2. Product/Service Landscape
10.1.3. Financial Overview
10.1.4. Recent Developments
10.2. Agilent Technologies, Inc.
10.2.1. Company Overview
10.2.2. Product/Service Landscape
10.2.3. Financial Overview
10.2.4. Recent Developments
10.3. Danaher Corporation
10.3.1. Company Overview
10.3.2. Product/Service Landscape
10.3.3. Financial Overview
10.3.4. Recent Developments
10.4. Perkinelmer, Inc.
10.4.1. Company Overview
10.4.2. Product/Service Landscape
10.4.3. Financial Overview
10.4.4. Recent Developments
10.5. Tecan Group
10.5.1. Company Overview
10.5.2. Product/Service Landscape
10.5.3. Financial Overview
10.5.4. Recent Developments
10.6. Axxam S.P.A.
10.6.1. Company Overview
10.6.2. Product/Service Landscape
10.6.3. Financial Overview
10.6.4. Recent Developments
10.7. Bio-Rad Laboratories
10.7.1. Company Overview
10.7.2. Product/Service Landscape
10.7.3. Financial Overview
10.7.4. Recent Developments
10.8. Merck Group
10.8.1. Company Overview
10.8.2. Product/Service Landscape
10.8.3. Financial Overview
10.8.4. Recent Developments
10.9. Hamilton Company
10.9.1. Company Overview
10.9.2. Product/Service Landscape
10.9.3. Financial Overview
10.9.4. Recent Developments
10.10. Corning Incorporated
10.10.1. Company Overview
10.10.2. Product/Service Landscape
10.10.3. Financial Overview
10.10.4. Recent Developments
10.11. Biotek Instruments
10.11.1. Company Overview
10.11.2. Product/Service Landscape
10.11.3. Financial Overview
10.11.4. Recent Developments
10.12. Aurora Biomed
10.12.1. Company Overview
10.12.2. Product/Service Landscape
10.12.3. Financial Overview
10.12.4. Recent Developments
The High Throughput Screening Market has been segmented as below:
High Throughput Screening Market, By Technology
High Throughput Screening Market, By Product
High Throughput Screening Market, By Application
High Throughput Screening Market, By End-Use
High Throughput Screening Market, By Region
SUBSCRIBE TO OUR NEWSLETTERS
